About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

20 Yale J.L. & Tech. 1 (2018)

handle is hein.journals/yjolt20 and id is 1 raw text is: 




       The Drug Repurposing Ecosystem:
   Intellectual Property Incentives, Market
          Exclusivity, and the Future of
                   New Medicines

                       Sam F. Halabil

               20 YALE J. L. & TECH. 1 (2018)

    The   pharmaceutical    industry   is  in   a  state  of
fundamental transition. New drug approvals have slowed,
patents on blockbuster drugs are expiring, and costs
associated with developing new drugs are escalating and
yielding  fewer   viable  drug   candidates. As    a  result,
pharmaceutical firms      have   turned  to  a   number   of
alternative strategies for growth. One of these strategies is
drug rep urposing-finding new ways to deploy approved
drugs or abandoned clinical candidates in new disease
areas. Despite the efficiency advantages of repurposing
drugs, there is broad agreement that there is insufficient
repurposing activity because of numerous intellectual
property protection and market failures. This Article
examines the system that surrounds drug repurposing,
including serendipitous discovery, the application of big
data   methods    to  prioritize  promising    repurposing
candidates,     the   unorthodoxly     regulated    off-label
prescription   practices   of   providers,    and    related
prohibitions    on    pharmaceutical      firms'    off-label
marketing. The Article argues that there is a complex
ecosystem in place and that additional or disruptive IP

Fulbright Canada Research Chair in Health Law, Policy, and Ethics,
University of Ottawa and Associate Professor, University of Missouri School of
Law.; J.D. Harvard; M.Phil. The University of Oxford (St. Antony's
College); B.A., B.S. Kansas State University. The author is grateful for
comments and helpful suggestions given at faculty workshops at Arizona
State University's Sandra Day O'Connor School of Law, Boston University's
biolP Faculty Workshop, and Seton Hall University School of Law, as well as
the American Society of Law, Medicine, and Ethics' Annual Health Law
Professors Conference. Particular thanks go to Mark Bartholomew, Jenelle
Beavers, Carl Coleman, Paul Gugliuzza, Yaniv Heled, Cynthia Ho, John
Jacobi, Kristin Johnson, Dmitry Karshtedt, Aaron Kesselheim, Renee
Landers, Peter Lee, Erika Lietzan, Maggie Lewis, Molly McBurney, Michael
Meurer, Fran Miller, Emily Michiko Morris, Kevin Outterson, Jordan
Paradise, Michael Risinger, Alice Ristroph, Christopher Robertson, William
Sage, Brian Shephard, Michael Simkovic, Ashley Stevens, Liza Vertinsky,
and Kathy Zeiler. Special thanks go to Katie Spraberry for excellent research
assistance.

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Short-term subscription options include 24 hours, 48 hours, or 1 week to HeinOnline.

Contact us for annual subscription options:

Already a HeinOnline Subscriber?

profiles profiles most